Advertisement

The Role of Combined Chemotherapy and Radiation Therapy in the Treatment of Gynecologic Malignancies

  • Patricia J. Eifel
Chapter
Part of the Cancer Drug Discovery and Development book series (CDD&D)

Abstract

In women with lower-genital-tract carcinomas—cervical, vaginal, and vulvar carcinomas—hematogenous metastases are rarely present at diagnosis, and thus disease can frequently be controlled with local treatment. Small tumors can usually be treated with surgery alone, but cancers that penetrate deeply, particularly those that involve adjacent tissues or regional lymph nodes, require radiation therapy. Although radiation therapy controls pelvic disease in many cases, local and regional recurrence frequently contributes to the death of patients who are not cured with local treatment. To reduce these recurrences and improve cure rates, investigators have sought effective ways of combining chemotherapy with radiation therapy.

Keywords

Cervical Cancer Radiat Oncol Biol Phys Radiation Therapy Oncology Group Vulvar Cancer Gynecologic Oncology Group 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Sinclair W. The combined effect of hydroxyurea and x-rays on Chinese hamster cells in vitro. Cancer Res 1968; 28: 198–201.PubMedGoogle Scholar
  2. 2.
    Hreshchyshyn MM. Hydroxyurea with irradiation for cervical carcinoma—preliminary report. Cancer Chem Rep 1968; 52: 601–602.Google Scholar
  3. 3.
    Piver M, Barlow J, Vongtama V, et al. Hydroxyurea and radiation therapy in advanced cervical cancer. Am J Obstet Gynecol 1974; 120: 969–972.PubMedGoogle Scholar
  4. 4.
    Piver M, Barlow J, Vongtama V, et al. Hydroxyurea as a radiation sensitizer in women with carcinoma of the uterine cervix. Am J Obstet Gynecol 1977; 129: 379–383.PubMedGoogle Scholar
  5. 5.
    Piver MS, Barlow JJ, Vongtama V, et al. Hydroxyurea: A radiation potentiator in carcinoma of the uterine cervix. A randomized double-blind study. Am J Obstet Gynecol 1983; 147: 803–808.PubMedGoogle Scholar
  6. 6.
    Piver MS, Krishnamsetty RM, Emrich LJ. Survival of nonsurgically staged patients with negative lymphangiograms who had stage IIB carcinoma of the cervix treated by pelvic radiation plus hydroxyurea. Obstet Gynecol 1985; 151: 1006–1008.Google Scholar
  7. 7.
    Piver M, Vongtama V, Emtrich L. Hydroxyurea plus pelvic radiation versus placebo plus pelvic radiation in surgically staged stage IIIB cervical cancer. J Surg Oncol 1987; 35: 129–134.PubMedCrossRefGoogle Scholar
  8. 8.
    Piver MS, Barlow JJ. High dose irradiation to biopsy confirmed aortic node metastases from carcinoma of the uterine cervix. Cancer 1977; 39: 1243–1246.PubMedCrossRefGoogle Scholar
  9. 9.
    Hreshchyshyn MM, Aron BS, Boronow RC, et al. Hydroxyurea or placebo combined with radiation to treat stages IIIB and IV cervical cancer confined to the pelvis. Int JRadiat Oncol Biol Phys 1979; 5: 317–322.CrossRefGoogle Scholar
  10. 10.
    Stehman FB, Bundy BN, Keys H, et al. A randomized trial of hydroxyurea versus misonidazole adjunct to radiation therapy in carcinoma of the cervix. A preliminary report of a Gynecologic Oncology Group study. Am J Obstet Gynecol 1988; 159: 87–94.PubMedGoogle Scholar
  11. 11.
    Stehman FB, Bundy BN, Thomas G, et al. Hydroxyurea versus misonidazole with radiation in cervical carcinoma: long-term follow-up of a Gynecologic Oncology Group trial. J Clin Oncol 1993; 11: 1523 1528.Google Scholar
  12. 12.
    Rose PG, Bundy BN, Watkins J, et al. Concurrent cisplatin-based chemotherapy and radiotherapy for locally advanced cervical cancer. N Engl J Med 1999; 340: 1144–1153.PubMedCrossRefGoogle Scholar
  13. 13.
    Whitney CW, Sause W, Bundy BN, et al. A randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stages IIB–IVA carcinoma of the cervix with negative para-aortic lymph nodes: A Gynecologic Oncology Group and Southwest Oncology Group study. J Clin Oncol 1999; 17: 1339–1348.PubMedGoogle Scholar
  14. 14.
    Thigpen T, Shingleton H, Homesley H, et al. Cis-platinum in treatment of advanced or recurrent squamous cell carcinoma of the cervix. Cancer 1981; 48: 899–903.PubMedCrossRefGoogle Scholar
  15. 15.
    Souhami L, Gil R, Allan S, et al. A randomized trial of chemotherapy followed by pelvic radiation therapy in stage IIIB carcinoma of the cervix. Int J Radiat Oncol Biol Phys 1991; 9: 970–997.Google Scholar
  16. 16.
    Tattersall MHN, Ramirez C, Coppleson M. A randomized trial comparing platinum-based chemotherapy followed by radiotherapy vs. radiotherapy alone in patients with locally advanced cervical cancer. Int J Gynecol Cancer 1992; 2: 244–251.PubMedCrossRefGoogle Scholar
  17. 17.
    Keys HM, Bundy BN, Stehman FB, et al. Cisplatin, radiation, and adjuvant hysterectomy for bulky stage IB cervical carcinoma. N Engl J Med 1999; 340: 1154–1161.PubMedCrossRefGoogle Scholar
  18. 18.
    Morris M, Eifel Pi, Lu J, et al. Pelvic radiation with concurrent chemotherapy compared with pelvic and paraaortic radiation for high-risk cervical cancer. N Engl J Med 1999; 340: 1137–1143.PubMedCrossRefGoogle Scholar
  19. 19.
    Peters WA, 3rd, Liu PY, Barrett RJ, 2nd, et al. Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix. J Clin Oncol 2000; 18: 1606–1613.PubMedGoogle Scholar
  20. 20.
    Pearcey RG, Brundage MD, Drouin P, et al. Phase III trial comparing radical radiotherapy with and without cisplatin chemotherapy in patients with advance squamous cell cancer of the cervix. J Clin Oncol 2002; 20: 966–972.PubMedCrossRefGoogle Scholar
  21. 21.
    Chaney AW, Eifel PJ, Logsdon MD, et al. Mature results of a pilot study of pelvic radiotherapy with concurrent continuous infusion intra-arterial 5-FU for stage IIIB-IVA squamous cell carcinoma of the cervix. Int J Radiat Oncol Biol Phys 1999; 45: 113–118.PubMedCrossRefGoogle Scholar
  22. 22.
    Thomas G, Dembo A, Ackerman I, et al. A randomized trial of standard versus partially hyperfractionated radiation with or without concurrent 5-fluorouracil in locally advanced cervical cancer. Gynecol Oncol 1998; 69: 137–145.PubMedCrossRefGoogle Scholar
  23. 23.
    Christie DR, Bull CA, Gebski V, et al. Concurrent 5-fluorouracil, mitomycin C and irradiation in locally advanced cervix cancer. Radiother Oncol 1995; 37: 181–189.PubMedCrossRefGoogle Scholar
  24. 24.
    Lupi G, Raspagliesi F, Zucali R, et al. Combined preoperative chemoradiotherapy followed by radical surgery in locally advanced vulvar carcinoma. A pilot study. Cancer 1996; 77: 1472–1478.PubMedCrossRefGoogle Scholar
  25. 25.
    Rakovitch E, Fyles AW, Pintilie M, et al. Role of mitomycin C in the development of late bowel toxicity following chemoradiation for locally advanced carcinoma of the cervix. Int J Radiat Oncol Biol Phys 1997; 38: 979–987.PubMedCrossRefGoogle Scholar
  26. 26.
    Han SC, Kim DH, Higgins SA, et al. Chemoradiation as primary or adjuvant treatment for locally advanced carcinoma of the vulva. Int J Radiat Oncol Biol Phys 2000; 47: 1235–1244.PubMedCrossRefGoogle Scholar
  27. 27.
    Roberts KB, Urdaneta N, Vera R, et al. Interim results of a randomized trial of mitomycin C as an adjunct to radical radiotherapy in the treatment of locally advanced squamous-cell carcinoma of the cervix. Int J Cancer 2000; 90:206–223PubMedCrossRefGoogle Scholar
  28. 28.
    Wong LC, Ngan HY, Cheung AN, et al. Chemoradiation and adjuvant chemotherapy in cervical cancer. J Clin Oncol 1999; 17: 2055–2060.PubMedGoogle Scholar
  29. 29.
    Pignata S, Frezza P, Tramontana S, et al. Phase I study with weekly cisplatin-paclitaxel and concurrent radiotherapy in patients with carcinoma of the cervix uteri. Ann Oncol 2000; 11: 455–459.PubMedCrossRefGoogle Scholar
  30. 30.
    Chen MD, Paley PJ, Potish RA, et al. Phase I trial of taxol as a radiation sensitizer with cisplatin in advanced cervical cancer. Gynecol Oncol 1997; 67: 131–136.PubMedCrossRefGoogle Scholar
  31. 31.
    Muderspach LI, Curtin JP, Roman LD, et al. Carboplatin as a radiation sensitizer in locally advanced cervical cancer: a pilot study. Gynecol Oncol 1997; 65: 336–342.PubMedCrossRefGoogle Scholar
  32. 32.
    Wong L, Choo Y, Choy D, et al. Long-term follow-up of potentiation of radiotherapy by cis-platinum in advanced cervical cancer. Gynecol Oncol 1989; 35: 159–163.PubMedCrossRefGoogle Scholar
  33. 33.
    Formenti SC, Meyerowitz BE, Ell K, et al. Inadequate adherence to radiotherapy in Latina immigrants with carcinoma of the cervix. Potential impact on disease free survival. Cancer 1995; 75: 1135–1140.PubMedCrossRefGoogle Scholar
  34. 34.
    Katz A, Eifel PJ, Moughan J, et al. Socioeconomic characteristics of patients with squamous cell carcinoma of the uterine cervix treated with radiotherapy in the 1992 to 1994 patterns of care study. Int J Radiat Oncol Biol Phys 2000; 47: 443–450.PubMedCrossRefGoogle Scholar
  35. 35.
    Thomas G, Dembo A, Fyles A, et al. Concurrent chemoradiation in advanced cervical cancer. Gynecol Oncol 1990; 38: 446 151.Google Scholar
  36. 36.
    Iversen T. Irradiation and bleomycin in the treatment of inoperable vulval carcinoma. Acta Obstet Gynecol Scand 1982; 61: 195–197.PubMedCrossRefGoogle Scholar
  37. 37.
    Scheistroen M, Trope C. Combined bleomycin and irradiation in preoperative treatment of advanced squamous cell carcinoma of the vulva. Acta Oncol 1992; 32: 657–661.CrossRefGoogle Scholar
  38. 38.
    AU A, AU M, Boike G, et al. Preliminary results of chemoradiation as a primary treatment for vulvar carcinoma. Int J Radiat Oncol Biol Phys 2000; 48:415–420PubMedCrossRefGoogle Scholar
  39. 39.
    Berek JS, Heaps JM, Fu YS, et al. Concurrent cisplatin and 5-fluorouracil chemotherapy and radiation therapy for advanced-stage squamous carcinoma of the vulva. Gynecol Oncol 1991; 42: 197–201.PubMedCrossRefGoogle Scholar
  40. 40.
    Cunningham MJ, Goyer RP, Gibbons SK, et al. Primary radiation, cisplatin, and 5-fluorouracil for advanced squamous carcinoma of the vulva. Gynecol Oncol 1997; 66: 258–261.PubMedCrossRefGoogle Scholar
  41. 41.
    Eifel PJ, Morris M, Burke TW, et al. Preoperative continuous infusion cisplatinum and 5-fluorouracil with radiation for locally advanced or recurrent carcinoma of the vulva. Gynecol Oncol 1995; 59: 51–56.PubMedCrossRefGoogle Scholar
  42. 42.
    Evans LS, Kersh CR, Constable WC, et al. Concomitant 5-fluorouracil, mitomycin-C, and radiotherapy for advanced gynecologic malignancies. Int J Radiat Oncol Biol Phys 1988; 15: 901–906.PubMedCrossRefGoogle Scholar
  43. 43.
    Koh WJ, Wallace HJ, Greer BE, et al. Combined radiotherapy and chemotherapy in the management of local-regionally advanced vulvar cancer. Int J Radiat Oncol Biol Phys 1993; 26: 809–816.PubMedCrossRefGoogle Scholar
  44. 44.
    Landoni F, Maneo A, Zanetta G, et al. Concurrent preoperative chemotherapy with 5-fluorouracil and mitomycin C and radiotherapy (FUMIR) followed by limited surgery in locally advanced and recurrent vulvar carcinoma. Gynecol Oncol 1996; 61: 321–327.PubMedCrossRefGoogle Scholar
  45. 45.
    Levin W, Goldberg G, Altaras M, et al. The use of concomitant chemotherapy and radiotherapy prior to surgery in advanced stage carcinoma of the vulva. Gynecol Oncol 1986; 25: 20–25.PubMedCrossRefGoogle Scholar
  46. 46.
    Moore DH, Thomas GM, Montana GS, et al. Preoperative chemoradiation for advanced vulvar cancer: a phase II study of the Gynecologic Oncology Group. Int J Radiat Oncol Biol Phys 1998; 42: 79–85.PubMedCrossRefGoogle Scholar
  47. 47.
    Russell AH, Mesic JB, Scudder SA, et al. Synchronous radiation and cytotoxic chemotherapy for locally advanced or recurrent squamous cancer of the vulva. Gynecol Oncol 1992; 47: 14–20.PubMedCrossRefGoogle Scholar
  48. 48.
    Thomas G, Dembo A, DePetrillo A, et al. Concurrent radiation and chemotherapy in vulvar carcinoma. Gynecol Oncol 1989; 34: 263–267.PubMedCrossRefGoogle Scholar
  49. 49.
    Wahlen SA, Slater JD, Wagner RI, et al. Concurrent radiation therapy and chemotherapy in the treatment of primary squamous cell carcinoma of the vulva. Cancer 1995; 75: 2289–2294.PubMedCrossRefGoogle Scholar
  50. 50.
    Leiserowitz GS, Russell AH, Kinney WK, et al. Prophylactic chemoradiation of inguinofemoral lymph nodes in patients with locally extensive vulvar cancer. Gynecol Oncol 1997; 66: 509–514.PubMedCrossRefGoogle Scholar
  51. 51.
    Montana GS, Thomas GM, Moore DH, et al. Preoperative chemo-radiation for carcinoma of the vulva with N2/N3 nodes: A Gynecologic Oncology Group study. Int J Radiat Oncol Biol Phys 2000; 48: 1007–1013.PubMedCrossRefGoogle Scholar
  52. 52.
    Eifel Pi. Chemoradiation for carcinoma of the cervix: Advances and opportunities. Radiat Res 2000; 154: 229–236.PubMedCrossRefGoogle Scholar
  53. 53.
    Kumar L, Kaushal R, Nandy M, et al. Chemotherapy followed by radiotherapy versus radiotherapy alone in locally advanced cervical cancer: A randomized study. Gynecol Oncol 1994; 54: 307–315.PubMedCrossRefGoogle Scholar
  54. 54.
    Chauvergne J, Rohart J, Héron JF, et al. Essai randomisé de chimiothérapie initiale dans 151 carcinomes du col utérin localement étendus (T2b-N1, T3b, MO). Bull Cancer 1990; 77: 1007–1024.PubMedGoogle Scholar
  55. 55.
    Tattersall MHN, Larvidhaya V, Vootiprux V, et al. Randomized trial of epirubicin and cisplatin chemotherapy followed by pelvic radiation in locally advanced cervical cancer. Am J Clin Oncol 1995; 13: 444–451.Google Scholar
  56. 56.
    Sunditór K, Trope CG, Hogberg T, et al. Radiotherapy and neoadjuvant chemotherapy for cervical carcinoma. A randomized multicenter study of sequential cisplatin and 5-fluorouracil and radiotherapy in advanced cervical carcinoma stage 3B and 4A. Cancer 1996; 77: 2371–2378.CrossRefGoogle Scholar
  57. 57.
    Leborgne F, Leborgne JH, Doldân R, et al. Induction chemotherapy and radiotherapy of advanced cancer of the cervix: A pilot study and phase III randomized trial. Int J Radiat Oncol Biol Phys 1997; 37: 343–350.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2003

Authors and Affiliations

  • Patricia J. Eifel

There are no affiliations available

Personalised recommendations